2,633 Shares in Tenet Healthcare Corporation $THC Acquired by Elevation Point Wealth Partners LLC

Elevation Point Wealth Partners LLC acquired a new stake in Tenet Healthcare Corporation (NYSE:THC) during the first quarter, HoldingsChannel reports. The fund acquired 2,633 shares of the company’s stock, valued at approximately $497,000.

Other hedge funds have also bought and sold shares of the company. Caption Management LLC purchased a new stake in Tenet Healthcare during the third quarter valued at about $5,650,000. Eminence Capital LP purchased a new position in Tenet Healthcare in the 3rd quarter valued at approximately $225,263,000. Sirios Capital Management L P raised its holdings in Tenet Healthcare by 100.9% during the 3rd quarter. Sirios Capital Management L P now owns 71,566 shares of the company’s stock valued at $14,531,000 after acquiring an additional 35,947 shares during the period. Algert Global LLC lifted its position in shares of Tenet Healthcare by 21.8% during the third quarter. Algert Global LLC now owns 50,379 shares of the company’s stock worth $10,229,000 after acquiring an additional 9,000 shares in the last quarter. Finally, Braidwell LP purchased a new position in shares of Tenet Healthcare in the third quarter valued at $24,710,000. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Stock Performance

NYSE THC opened at $206.13 on Thursday. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The company has a fifty day moving average of $182.82 and a 200-day moving average of $197.56. The company has a market capitalization of $17.76 billion, a P/E ratio of 10.72, a P/E/G ratio of 1.72 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.39 billion. During the same quarter last year, the business posted $4.36 earnings per share. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts predict that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Wall Street Analyst Weigh In

THC has been the subject of a number of recent analyst reports. Morgan Stanley set a $254.00 target price on Tenet Healthcare in a report on Friday, May 1st. Wells Fargo & Company decreased their target price on shares of Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Guggenheim decreased their price target on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Royal Bank Of Canada lowered their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating on the stock in a research report on Friday, May 1st. Finally, Wall Street Zen cut Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, May 11th. Eighteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $244.32.

Insider Transactions at Tenet Healthcare

In related news, Director Nadja West sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $177.35, for a total value of $532,050.00. Following the completion of the sale, the director owned 24,805 shares in the company, valued at $4,399,166.75. The trade was a 10.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the sale, the director directly owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This trade represents a 25.12% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.97% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.